A 6-month, double-blinded, placebo-controlled trial for DPN patients demonstrated that oral ALA (600 mg twice daily) significantly improved neurological symptom scores (NSS), neurological disability scores (NDS), VAS, and VPT compared to placebo
This protective effect is mediated through mechanisms such as the enhancement of antioxidant enzymes, including superoxide dismutase (SOD) and GSH, activation of the Nrf2 pathway, and modulation of autophagy via the PI3K/AKT/mTOR and AMPK/mTOR/ULK1 pathways
The cell viability and melanin quantification assay demonstrate that 50 M of T1 apparently attenuates 20% melanin content of human normal melanocytes without significant cell toxicity
It is important to consider any medical conditions when determining the frequency of B12 injections
Summarizes wound/tissue-repair effects across animal models, but not veterinary clinical trials
Ipamorelin GHS-R1a Ghrelin Receptor Pathway Ipamorelin acts via GHS-R1a through a mechanism distinct from the GHRH pathway activating phospholipase C and mobilising intracellular calcium stores in somatotroph cells
.png)
